Tuesday, 13 July 2021

The 10-Year Overnight Success Story Of CupriDyne® Clean, The Odor & VOC Control Product That Actually Works

CupriDyne Clean is a clean-chemistry odor and VOC control product that has been proven in side-by-side comparisons to deliver the #1 performance in the odor control industry. It is a gentle, non-toxic, eco-friendly, formula that uses novel iodine chemistry to break down odor-causing compounds rather than masking them. The product, made by cleantech and environmental engineering company BioLargo, Inc. (BLGO: OTCQB), is used to combat some of the toughest odors and air quality contaminants in the world at landfills, wastewater plants, cannabis production and processing sites, and other industrial facilities – what is collectively known as the ‘industrial odor control’ market. Until CupriDyne Clean came along, this industry settled for fragrances and masking agents (sometimes dressed up with clever marketing language like ‘encapsulators’ or ‘essential oils’) to fight their odor problems. CupriDyne Clean, on the other hand, actually breaks down odor-causing compounds, providing substantially better performance. Customers noticed.

ONM Environmental, BioLargo’s subsidiary that manufactures and sells CupriDyne Clean, has achieved healthy sales growth for the product over the past three years, due in part to its national purchasing agreements with leading companies in the municipal solid waste industry. More recently, they’ve taken on some of the largest municipal public works clients in the region. Now they aim to accelerate sales growth for the product through key strategic partnerships with industry veterans, a strategy exemplified by BioLargo’s partnerships with 112-year-old North American wastewater services company Garratt-Callahan and BKT Co., a leader in wastewater treatment in South Korea. The wastewater market is ideal for CupriDyne Clean, which has been proven effective at eliminating odorous hydrogen sulfide, a common air contaminant arising from wastewater[2].

How CupriDyne Started Out

CupriDyne didn’t start out as an industrial product. The formula behind CupriDyne Clean started out as an odor control product in the niche livestock and equine markets, then subsequently consumer products were developed for pet stain and odor control. Although the formula was well-reviewed because of its unparalleled odor elimination kinetics (receiving two industry “Product of the Year” awards and several “Editor’s Choice” awards), it never gained widespread market adoption as a consumer product.

Six years after the initial CupriDyne-based products launched in the pet, livestock, and equine market, ONM Environmental (then known as Odor-No-More) was recruited by a waste handling industry leader to develop BioLargo’s chemistry into an industrial odor and VOC control product that could be used to solve large-scale air quality problems. According to that waste handling veteran, the waste industry had put up with poor-performing odor control products for decades, to the point where many waste handling operators were highly skeptical of most odor control products. It was clearly an industry in need of a solution that actually works.

CupriDyne Clean was born: a non-toxic, gentle, environmentally friendly, and safe solution to help manage industrial odor and VOC control challenges. Most importantly, unlike other odor and VOC control products common in the industrial sector, CupriDyne Clean actually breaks down odor-causing compounds, meaning it provides long-lasting efficacy in applications where the odors are strong and plentiful.

BioLargo leadership is confident the CupriDyne formula still has a significant future in consumer odor and VOC (volatile organic compound) control markets. The product has been vetted by third-party studies to be a night-and-day superior technical performer compared to major incumbent brands, and its claims of eco-friendliness and non-toxicity make it an appealing solution for everyday odor problems. Company management is confident that with the right partners, the product will soar in the consumer market.

Finding its Niche

“Not smelling is believing”, a phrase coined by ONM Environmental President Joseph Provenzano is why customers love CupriDyne Clean and keep coming back for more. An example of an early pivotal moment for the CupriDyne Clean industrial odor product was in early 2017 when a Florida landfill customer ordered on the spot after one application of CupriDyne powder to dry wastewater treatment sludge (infamously stinky) reduced odors immediately. Just like that, a key moment with a decision-maker smelling the effect of CupriDyne led to one of the product’s first big deals. Later that year the ONM team signed a deal with a leading integrated solid waste and recycling services company. Now, the company has signed other integrated waste handlers who collectively operate 1,200+ facilities, transfer stations, and landfills located in 39 states and six provinces throughout North America. By June of 2018, CupriDyne Clean’s superior performance and price advantage over competing products increased adoption among the top four waste handling companies in the US[3].

Another important moment for CupriDyne Clean came in the spring of 2019 during the rise of cannabis cultivation in North America, which presented a “pick & shovel” opportunity to supply CupriDyne Clean as a crucial tool the industry’s growing odor and VOC problem[4]. Southern Air Systems Corp (SAS) out of Knoxville Tennessee, analyzed the two main odor-causing terpenes (odorous VOCs that result from cannabis cultivation) and concluded, “after treatment with CupriDyne Clean, no trace of terpenes was detected in the air samples.”[5] By April of 2019, BioLargo signed a 5-year white-label distribution agreement with a sister company of Mabre Air Systems and began offering CupriDyne Clean under the brand name “Cannabusters.”[6] In early 2021 Cannabusters signed a sub-distributor with more than 30 years of history in deployment systems. As the cannabis industry matures more jurisdictions will require cultivators to enact air quality control measures to mitigate odor-causing terpenes like in Los Angeles County.

2020 was off to a great start when CEO of ONM Environmental Joe Provenzano, was published in Waste Advantage Magazine highlighting their work in waste handling. Shortly after, the team launched a joint venture with BKT and Tomorrow Water, a leading wastewater treatment solutions provider with operations in Daegu, South Korea, one of the leading cleantech innovation centers in Asia. BKT has an extensive distribution network throughout Southeast Asia serving more than 400 customers in South Korea alone with a presence in eight countries globally[7]. In early 2021, ONM Environmental acquired deodorizing and sanitizing technology, EcoMist, that helps solid waste collectors treat all types of waste receptacles in real time during pick up[8].

CupriDyne Clean in the Global Odor Control Market

The global odor control market is expected to grow at a CAGR of 4.9% and reach $11.15 billion by 2022 according to a limited study by Research and Markets[9].

The U.S. waste handling industry market value for odor control equipment is estimated at $1.3 billion annually, and was forecasted to hit $9.2 billion globally in 2019[10]. Wastewater treatment revenues in the United States amounted to $63 billion in 2018[11] and as their role in regulatory-driven food waste recycling and potable reuse markets increase, so too does odor-elimination demand within wastewater treatment[12]. The U.S. cannabis industry is worth $61 billion[13]contributing to the increased demand for odor control at cultivation sites. The growing demand in household, pets, livestock and equine odor elimination sectors are also inclining. As demand for odor-elimination products increase from complaints, regulatory violations, and litigation, BioLargo is well positioned for continued growth.

While some enzyme-based solutions do eliminate some odor-causing compounds, they often have a limited range of activity, take some time to work, and can be costly. CupriDyne Clean, on the other hand, doesn’t just mask the odor-causing compounds and other VOCs, it breaks them down through oxidation, meaning it is better at improving air quality. Masking agents, encapsulators and neutralizers do not work – odor molecules stick to everything and inevitably begin to smell again. CupriDyne Clean offers substantial savings to our customers compared with competing products that not only cleans, but also eliminates odors.

CEO of BioLargo, Inc. (OTCQB:OTCQB:BLGO) Dennis P. Calvert commented, “Our product CupriDyne Clean tackles odors that no other product can, and it does it while being safe, environmentally friendly, and economical. A product like that has a home all across the global odor control market.”

Holding patents in absorbency, antimicrobial activityand anti-odor solutions and delivery systems, the formula behind BioLargo’s CupriDyne products have a definite future beyond the industrial odor control markets. The hardest work is already done to achieve that goal – the product has been developed, validated, and proven in countless applications to be the #1 performing odor elimination product. The company is also in the process with the EPA to register a CupriDyne-based product for advanced sanitization and disinfection claims. Furthermore, because of the product’s successes the company is in talks with prospective consumer packaged goods (CPG) companies about launching a CupriDyne-based consumer product done through distribution partnerships. Despite finding a real and growing market for the product in industrial and commercial settings, BioLargo may yet see its clean-chemistry odor and VOC control product populate store shelves someday soon, and company management looks forward to sharing more information about that soon.


[1] Odor Control System Market Size, Opportunity & Forecast 2026

[2] BioLargo's CupriDyne Clean Proven Effective in Eliminating Hydrogen Sulfide Through Third-Party Lab Testing

[3] BioLargo® Spotlight: Odor-No-More® Leverages Turn-Key Engineering Services and Top-Performing Products for Unsurpassed Industrial Odor and VOC Control

[4] Press Release - BioLargo Supplies Odor and VOC Control Solution to Cannabis Industry: An Uptick Newswire Stock Day Podcast Interview

[5] BioLargo’s CupriDyne Clean Eliminates Cannabis Odors - Third-Party Validated Study

[6] BioLargo's Odor-No-More Enters Cannabis and Hemp Odor Control Industry with Experienced Distribution Partner Through White Label Agreement

[7] BioLargo Expands Global Reach, Signs Joint Venture Agreement with BKT & Tomorrow Water featuring CupriDyne Clean Based Products

[8] BioLargo’s ONM Environmental Acquires EcoMist Trash Receptacle Spray Technology

[9] Odor Eliminator Market - Drivers, Opportunities, Trends & Forecasts up to 2022

[10] Tamarack Article - Industrial Odor Control is Big Business

[11] Revenue from U.S. wastewater treatment | Statista

[12] Wastewater Markets | Climate Change Industry | Climate Change Business Journal

[13] Cannabis Industry Statistics for 2021 

Friday, 2 July 2021

BioLargo highlights its engineering division's recent contract wins




BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert and its engineering subsidiary CEO Randall Moore tell Proactive it has recently been notified of several new contract awards worth more than $1.2 million in revenue, most of which will be earned over the next six months. The recent wins are expected to increase its operating cash flow, which will support its plans for top-line revenue growth and its efforts to commercialize several of its patented environmental technologies

Tuesday, 29 June 2021

BioLargo’s Engineering Subsidiary on a Hot Streak with New Contract Awards







Westminster, CA – June 29, 2021 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced that its engineering subsidiary has recently been notified of several new contract awards. These recent wins are expected to increase the company’s operating cash flow, which will support its plans for top-line revenue growth and its efforts to commercialize a number of BioLargo’s patented environmental technologies.

These new contract wins are for work with 1) a resin manufacturing facility, 2) a dairy farm, 3) a new project at Picatinny Arsenal, one of the company’s long-time customers, 4) a potato processing plant, and 5) a US Air Force base, adding to the other seven bases already served by the company. Together, the new contracts are worth more than $1.2 million in revenue, most of which will be earned over the next six months. 

Dennis P. Calvert, President and CEO of BioLargo commented, “We believe these recent contract wins are evidence that our engineering subsidiary is on a trajectory toward aggressive growth, both in revenues and capacity. More cash flow means they can bring on new talent and expand their reach and credibility in the market as a reliable solutions provider for pressing environmental challenges, and empowers them to commercialize our patented innovations, including our water treatment technologies.” 

BioLargo Engineering, Sciences and Technologies, LLC (BLEST), was created to support three critical business initiatives:

  1. Scaling up and commercializing BioLargo’s innovative environmental technologies like its Advanced Oxidation System (AOS) energy-efficient water treatment technology, currently preparing for commercial trials.
  2. Building a customer-focused business that delivers trusted expert advice and practical engineering solutions to tackle some of the toughest environmental challenges.
  3. Continuing the company’s rich history of innovation. BLEST has already developed a potentially market-disruptive water treatment technology for per- and polyfluoroalkyl substances, or PFAS (read more at our blog: https://bit.ly/3jmIyWN), as well as an industrial waste mineral extraction technology. Both of these opportunities are in the final stages of preparing for commercial launch.

Mr. Calvert finished by saying, “These contract wins are a testament to our engineers’ technical skill and reputation as trusted project integrators. These two aspects are what will drive our patented, high-value innovations into the market.”

  

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863 

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company’s business, results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

Monday, 21 June 2021

Peer-Reviewed Scientific Paper Confirms Safety of Water Treated by BioLargo’s Advanced Oxidation System

Study demonstrates AOS generates less disinfection by-products than common wastewater treatment technologies 

Westminster, CA – June 21, 2021 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced the publication of a peer-reviewed scientific paper about its patented energy-efficient water disinfection technology the Advanced Oxidation System (AOS). The paper, which focused on quantifying the disinfection by-products generated by the AOS, represents a critical milestone in the commercialization of BioLargo’s innovative water treatment technology.

BioLargo’s ground-breaking AOS technology is a water treatment platform that provides high-level disinfection and consumes less electricity than competing technologies such as UV and ozone-based systems.  Significantly, the AOS removes pharmaceutical micropollutants from water to provide added value across diverse water treatment applications, including municipal wastewater treatment.

The study, led by the laboratory of Dr. Susana Kimura-Hara at the University of Calgary, assessed the disinfection by-products (DBPs) generated by the BioLargo AOS. The paper concluded that the levels of DBPs generated by the AOS were comparable to those found in ordinary tap water.

The paper’s abstract and summary can be accessed here: https://www.sciencedirect.com/science/article/abs/pii/S0043135421005388

As all water treatment technologies generate DBPs, the quantity and relative safety of disinfection byproducts generated by a given water treatment technology is an important consideration for customers deciding which technology to select for their needs. The results of this study therefore represent an important milestone for the AOS, which has a municipal wastewater treatment demonstration pilot underway near Montréal, Québec and is currently being readied for commercial trials.

This study corroborates the results of another peer-reviewed paper published earlier this year that showed the AOS does not increase the toxicity of treated water. Notably, that study also showed the AOS to be capable of negating the negative effects of two hard-to-treat micropollutants, with the paper’s author Dr. Greg Goss calling the AOS, “a major technical breakthrough for the treatment of micropollutants.


About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company’s business, results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

 

Monday, 7 June 2021

BioLargo 2021 Annual Meeting of Stockholders Tuesday, June 15, 2021, 10:00 AM Pacific Time

Westminster, CA – June 7, 2021 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable clean- technologies and full-service environmental engineering company, will host its annual stockholder meeting on Tuesday June 15, 2021, at 10:00 am Pacific Time, via live webcast. In light of the continuing public health impact of the ongoing COVID-19 pandemic and to support the health and safety of the Company’s stockholders and attendees, the 2021 Annual Meeting will be held in a virtual-only meeting format.

Stockholders may register to attend the online Annual Meeting at this link:

https://agm.issuerdirect.com/blgo

Members of the Board and Management team will discuss the Company’s most recent annual and quarterly results and other general company matters, followed by a question-and-answer session with stockholders and management.

It is important that your shares be represented and voted at the Annual Meeting, whether or not you     plan to attend online. Stockholders of record as of April 19, 2021, may vote at the Annual Meeting. Please review the proxy statement and vote in accordance with the instructions you received.  

 

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

 

Friday, 4 June 2021

BioLargo (BLGO) to Present at LD Micro Invitational XI

Presentation on Wednesday, June 9 at 5:00 PM ET

Westminster, CA – June 4, 2021 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced today that it will be giving an investor presentation at the upcoming LD Micro virtual event on Wednesday, June 9, 2021, at 5:00 PM ET. BioLargo President and CEO Dennis P. Calvert will be giving the presentation.

Mr. Calvert will be discussing the company’s soon-to-launch sustainable water treatment technologies including its innovative solution for treating water contaminated with per- and polyfluoroalkyl substances (PFAS). Used in fire retardants and industrial facilities, PFAS contaminate municipal drinking water supplies across the country and the world, and represent a serious threat to human health.

“We got ahead of the curve by developing and commercializing an affordable and environmentally conscious technology that removes these toxic chemicals,” said Mr. Calvert. “The BioLargo AEC represents the most practical solution for this serious global problem. Watch our presentation to learn more about it and about our other emerging cleantech solutions.”

Event: BioLargo Presentation at the LD Micro Invitational XI

Date: Wednesday, June 9, 2021

Time: 5:00 PM Eastern

Register to watch the presentation at https://ldmicrojune2021.mysequire.com

Summary of LD Micro Invitational XI Event

The 2021 LD Micro Invitational will be held on the Sequire Virtual Events platform on Tuesday, June 8th - Thursday, June 10th, 2021.

This three-day, virtual investor conference is expected to feature around 180 companies, presenting for 25 minutes each, as well as several influential keynotes. The first day of this conference will also feature an exceptional one-time event: the LD Micro Hall of Fame.

 

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets. See our website at www.BioLargo.com.

About LD Micro (NASDAQ: SRAX)

LD Micro aims to be the most crucial resource in the micro-cap world. Whether it is the index, comprehensive data, or hosting the most significant events on an annual basis, LD's sole mission is for the Texas Rangers to win the World Series and serve as an invaluable asset for all those interested in finding the next generation of great companies.

http://www.ldmicro.com

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company’s business, results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

Thursday, 27 May 2021

BioLargo (BLGO) Discusses Elimination of Convertible Debt and Progress on Commercialization of PFAS Treatment Technology with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - May 27, 2021) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. President and CEO of BioLargo, Dennis P. Calvert, joined Stock Day host Everett Jolly for an interview.

Jolly began the interview by commenting on the company's latest announcements, including a recent press release detailing the elimination of almost all of the company's convertible debt. "We took quite a bit of risk [three years ago]; we needed that capital and we have put it to great work. We have advanced two platform technologies that are now at a commercial-ready stage, they're dramatic and they have a big future," said Calvert. "The opportunities that are coming to us are so big and so expansive, and it's really a tribute to our great technology and to our people."

"We really needed to get that convertible debt out of the way," continued Calvert, noting that the company's debt peaked at $7.6 million in 2018. "Since then, we have retired all [but $50,000] of this convertible debt, which has been continuing to put pressure on the stock. So, it's a great moment."

Jolly then commented on the company's recent revenues and growth. "I think we're just scratching the surface," said Calvert. "We have put a couple of really key relationships together. We have new technologies coming into our portfolio. We are incredibly active and dynamic in developing commercial and revenue opportunities of significance."

"Could you give us an update on the company's PFAS project?" asked Jolly. "It's a very exciting opportunity," said Calvert. "There is a mandate by the Biden Administration to get this cleaned up. The beauty of this situation is that we got a little bit of a head start before it crescendoed in the market, which means we have the talent and the technical solution advanced sufficiently to be in commercial mode now."

"We would like to be in the field within the next 60-120 days. [PFAS] is a contaminant that has to come out; it is the environmental disaster of the decade," he explained. "We just think this is such an enormous opportunity. We're going to take it from start to finish and prove that it is a commercially viable, economic, and environmentally-friendly solution. Then we're going to partner with companies and take it all over the world."

Calvert then elaborated on the potential customers for this industry, which will likely include the military, municipal, and industrial clients. "Who serves those people? There are really two classes: environmental engineering firms and specialty large companies dedicated to water," explained Calvert. "Both of those are really distributor and partner opportunities for us."

"What is the outlook for your company over the next twelve months?" asked Jolly. "The hardest work is done," said Calvert. "We have never been more excited than today... we have some financing that really provides the resources to get us through this commercial gap," he continued. "I think this is a time where investor enthusiasm is at an all-time high and it will continue. So, we're a company to watch."

"You need to watch carefully, because the evolution of this company is so dynamic that if you're not looking every six months you will only know about half the story," said Calvert. "The hard work is done, the prize is in front of us, let's go do the work and get it done."

To hear Dennis Calvert's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7875307-biolargo-blgo-discusses-elimination-of-convertible-debt-and-progress-on-commercialization-of-pf

Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/


About BioLargo, Inc.

BioLargo, Inc. (OTCQB: BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company's business, results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

About The "Stock Day" Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America.

SOURCE:

Stock Day Media

(602) 821-1102

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/85514